H
Hongxia Wang
Publications - 1
Citations - 30
Hongxia Wang is an academic researcher. The author has contributed to research in topics: Antigen processing & Cytotoxic T cell. The author has an hindex of 1, co-authored 1 publications receiving 7 citations.
Papers
More filters
Journal ArticleDOI
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.
Yixuan Zhou,Ingmar N. Bastian,Mark D. Long,Michelle Dow,Wei-Hua Li,Tao Liu,Rachael Katie Ngu,Laura Antonucci,Jian Yu Huang,Qui T. Phung,Xi-he Zhao,Xi-he Zhao,Sourav Banerjee,Sourav Banerjee,Xue-Jia Lin,Xue-Jia Lin,Hongxia Wang,Brian Dang,Sylvia Choi,Daniel Karin,Hua Su,Mark H. Ellisman,Christina Jamieson,Marcus Bosenberg,Zhang Cheng,Johannes Haybaeck,Johannes Haybaeck,Lukas Kenner,Lukas Kenner,Kathleen M. Fisch,Richard Bourgon,Genevive Hernandez,Jennie R. Lill,Song Liu,Hannah Carter,Ira Mellman,Michael Karin,Shabnam Shalapour,Shabnam Shalapour +38 more
TL;DR: In this article, the lysine acetyl transferases p300/CREB binding protein (CBP) and p300 ablations prevent chemotherapy-induced MHC-I AgPPM expression and neoantigen amounts in human cancers.